Shannon M. Parisotto - Feb 15, 2024 Form 4 Insider Report for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)

Signature
/s/ Shannon M. Parisotto
Stock symbol
CRL
Transactions as of
Feb 15, 2024
Transactions value $
-$567,818
Form type
4
Date filed
2/20/2024, 05:32 PM
Previous filing
Mar 25, 2024
Next filing
Mar 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRL Common Stock Sale -$69K -291 -3.43% $237.20 8.19K Feb 15, 2024 Direct F2
transaction CRL Common Stock Sale -$309K -1.29K -15.76% $239.28 6.9K Feb 15, 2024 Direct F3
transaction CRL Common Stock Sale -$388K -1.62K -23.44% $240.12 5.28K Feb 15, 2024 Direct F4
transaction CRL Common Stock Sale -$147K -610 -11.55% $241.28 4.67K Feb 15, 2024 Direct F5
transaction CRL Common Stock Sale -$153K -632 -13.53% $242.43 4.04K Feb 15, 2024 Direct F6
transaction CRL Common Stock Sale -$147K -604 -14.96% $243.96 3.43K Feb 15, 2024 Direct F7
transaction CRL Common Stock Sale -$183K -749 -21.81% $244.61 2.69K Feb 15, 2024 Direct F8
transaction CRL Common Stock Sale -$21.8K -89 -3.31% $245.34 2.6K Feb 15, 2024 Direct F9
transaction CRL Common Stock Options Exercise $851K +5.88K +226.58% $144.67 8.48K Feb 15, 2024 Direct
holding CRL Common Stock 29.4K Feb 15, 2024 by Karpathos Investments LLC F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRL Stock Options (Right to Buy) Options Exercise $0 -5.88K -100% $0.00* 0 Feb 15, 2024 Common Stock 5.88K $144.67 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Reflects the exempt transfer pursuant to Rule 16a-13 of 370 shares held by the reporting person to Karpathos Investments LLC.
F2 This transaction was executed in multiple trades at prices ranging from $236.71 to $237.56. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on February 23, 2023.
F3 This transaction was executed in multiple trades at prices ranging from $238.73 to $239.68. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on February 23, 2023.
F4 This transaction was executed in multiple trades at prices ranging from $239.76 to $240.55. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on February 23, 2023.
F5 This transaction was executed in multiple trades at prices ranging from $240.83 to $241.71. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on February 23, 2023.
F6 This transaction was executed in multiple trades at prices ranging from $241.97 to $242.67. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on February 23, 2023.
F7 This transaction was executed in multiple trades at prices ranging from $243.26 to $244.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on February 23, 2023.
F8 This transaction was executed in multiple trades at prices ranging from $244.27 to $45.24. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on February 23, 2023.
F9 This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on February 23, 2023.